Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06057675 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Tranexamic Acid in Nasal Mohs Reconstruction

StatusRecruiting
PhasePhase 2
Started2024-03-19
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 13 months later Jun 2026 → Aug 2027
See other at-risk trials from Vanderbilt University Medical Center

Amendment history

2026-09-06
Study Status v6
Primary completion pushed: 2026-06 → 2027-08
Completion pushed: 2026-06 → 2027-08
2025-08-17
Study Status v5
Primary completion date2025-12→2026-06
Completion date2025-12→2026-06
2025-02-16
Study Status v4
Primary completion date2024-12→2025-12
Completion date2024-12→2025-12
2024-05-09
Not Yet Recruiting→Recruiting Study Status, Eligibility, Contacts/Locations v3
Trial statusNot Yet Recruiting→Recruiting
Start dateestimated 2024-04→confirmed 2024-03-19
Study sites0→1
Eligibility criteria-141 characters
[...] story of coagulation disorder Active thromboembolic disease Current use of anticoagulant medication Severe renal impairment (diagnosis of chronic kidney disease) Uncontrolled diabetes preventing use of dexamethasone in the perioperative period Cardiac arrhythmia History of acute myocardial infarction History of stroke His [...]
2024-03-13
Study Status v2
Start date2024-02→2024-04
2024-01-15
Study Status v1
Start date2023-12→2024-02
2023-09-24
Original filing
This study will be a prospective randomized control trial to evaluate the effects of subcutaneously administered TXA among patients undergoing nasal Mohs reconstruction with local flaps at VUMC.
Trial Details
NCT Number NCT06057675
Lead Sponsor Vanderbilt University Medical Center
Conditions Postoperative Bleeding, Skin Cancer Face
Enrollment 100 participants
Start Date 2024-03-19
Primary Completion 2027-08 (estimated)
Study Completion 2027-08 (estimated)
Updated on ClinicalTrials.gov 2026-09-09